Boston Scientific Corporation (BSX)

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,502	865	928	1,925	1,734	217
Cash & Short-Term Investments	2,502	865	928	1,925	1,734	217
Cash Growth	162.82%	-6.79%	-51.79%	11.01%	699.08%	48.63%
Accounts Receivable	2,501	2,228	1,970	1,778	1,531	1,828
Receivables	2,501	2,228	1,970	1,778	1,531	1,828
Inventory	2,753	2,484	1,867	1,610	1,351	1,579
Restricted Cash	70	130	149	188	208	346
Other Current Assets	935	807	846	816	1,870	729
Total Current Assets	8,761	6,514	5,760	6,317	6,694	4,699
Property, Plant & Equipment	3,498	3,298	2,832	2,687	2,542	2,415
Long-Term Investments	532	413	407	411	918	458
Goodwill	15,033	14,387	12,920	11,988	9,951	10,176
Other Intangible Assets	5,758	6,033	5,969	6,235	6,135	8,218
Long-Term Deferred Tax Assets	3,816	3,841	3,942	4,142	4,210	4,196
Other Long-Term Assets	680	650	639	449	327	403
Total Assets	38,078	35,136	32,469	32,229	30,777	30,565
Accounts Payable	907	942	862	794	513	542
Accrued Expenses	2,272	2,136	1,855	1,883	1,666	1,583
Short-Term Debt	-	-	-	-	-	700
Current Portion of Long-Term Debt	1,652	531	20	261	13	716
Current Portion of Leases	-	76	61	71	70	67
Current Income Taxes Payable	286	220	232	209	158	265
Current Unearned Revenue	290	266	220	208	138	144
Other Current Liabilities	503	762	553	848	1,123	849
Total Current Liabilities	5,910	4,933	3,803	4,274	3,681	4,866
Long-Term Debt	9,229	8,566	8,910	8,798	9,123	8,586
Long-Term Leases	377	395	352	395	408	282
Long-Term Unearned Revenue	328	311	289	276	257	257
Long-Term Deferred Tax Liabilities	138	134	144	310	330	595
Other Long-Term Liabilities	1,140	1,267	1,398	1,554	1,652	2,102
Total Liabilities	17,122	15,606	14,896	15,607	15,451	16,688
Common Stock	17	17	17	17	17	16
Additional Paid-In Capital	20,963	20,647	20,289	19,986	19,732	17,561
Retained Earnings	2,107	819	-750	-1,392	-2,378	-2,253
Treasury Stock	-2,251	-2,251	-2,251	-2,251	-2,251	-1,717
Comprehensive Income & Other	-128	50	268	262	206	270
Total Common Equity	20,708	19,282	17,573	16,622	15,326	13,877
Minority Interest	248	248	-	-	-	-
Shareholders' Equity	20,956	19,530	17,573	16,622	15,326	13,877
Total Liabilities & Equity	38,078	35,136	32,469	32,229	30,777	30,565
Total Debt	11,258	9,568	9,343	9,525	9,614	10,351
Net Cash (Debt)	-8,756	-8,703	-8,415	-7,600	-7,880	-10,134
Net Cash Per Share	-5.91	-5.95	-5.84	-5.30	-5.56	-7.18
Filing Date Shares Outstanding	1,474	1,467	1,435	1,427	1,417	1,396
Total Common Shares Outstanding	1,473	1,466	1,433	1,426	1,417	1,395
Working Capital	2,851	1,581	1,957	2,043	3,013	-167
Book Value Per Share	14.05	13.16	12.26	11.66	10.82	9.95
Tangible Book Value	-83	-1,138	-1,316	-1,601	-760	-4,517
Tangible Book Value Per Share	-0.06	-0.78	-0.92	-1.12	-0.54	-3.24
Land	143	140	137	109	104	117
Buildings	1,912	1,843	1,695	1,523	1,292	1,198
Machinery	3,673	3,503	3,298	3,288	3,466	3,411
Construction In Progress	966	857	598	605	446	442

Source: S&P Capital IQ. Standard template. Financial Sources.